by michaelhalassa | May 14, 2025 | Cobenfy, KarXT
What Cobenfy Teaches Us About the Future of Psychiatric Drug Development The approval of Cobenfy (xanomeline-trospium) marks more than just the arrival of a new antipsychotic. It’s a signal—subtle but decisive—that the center of gravity in psychiatry may be shifting....
